Clinical and Radiological Effect Of Platelet Rich Fibrin on the Healing of Periodontal Intrabony Periodontal Defects

Baskent University15 enrolled

Overview

The aim of this split mouth, single-center, controlled study is to compare the healing of intrabony defects treated with a combination of Anorganic Bovine Bone Mineral (ABBM)/Platelet Rich Fibrin (PRF) or Anorganic Bovine Bone Mineral alone. The hypothesis being tested in the study was that PRF would augment the regenerative effects of ABBM in human intrabony defects.

Anorganic bovine bone mineral (ABBM) is extensively used in the treatment of intrabony defects. Platelet rich fibrin (PRF) is a new generation platelet concentrate with a simplified technique. Although there are some studies on the use of PRF in the treatment of intrabony defects, to date none of them evaluate its additive effects with ABBM. Therefore, a randomized, split mouth clinical trial was conducted to compare the healing of intrabony defects treated with a PRF/ABBM combination and to those obtained with ABBM alone. Using a split mouth design, 15 paired intrabony defects were randomly treated with either ABBM alone (control group) or with ABBM- PRF combination (test group). The following clinical parameters and radiographic measurements were recorded at baseline and six months postoperatively: plaque index (PI), gingival index (GI), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), vertical bone loss, the depth of the defect and defect angle

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Chronic Periodontitis Intrabony Periodontal Defect

Interventions

Anorganic Bovine Bone Mineral (ABBM)OTHER

In the control group, periodontal intrabony defects were treated with ABBM alone.

Anorganic Bovine Bone Mineral and Platelet Rich Fibrin (PRF)OTHER

In the test group, periodontal intrabony defects were treated with ABBM and PRF combination.

Eligibility

Min age: 38 YearsMax age: 61 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * no systemic diseases; * a good level of oral hygiene (OH) (plaque index\<0.15); * presence of two paired two-wall or three-wall intrabony defects with probing depth ≥6mm and an intrabony component ≥3mm as detected on radiographs; -no intrabony defects extending into the furcation area; * tooth mobility ≤1; * tooth and adjoining teeth testing vital and without symptoms or signs of endodontic involvement; * tooth and adjoining teeth free of caries or inadequate restorations. Exclusion Criteria: * patients with compromised immune systems; * pregnant and/or lactating women; * patients taking any drug known to affect the periodontal status or affect the coagulation system * smokers.

Locations (1)

Yasemin Sezgin

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

Clinical attachment level change: The distance from cemento-enamel junction to the depth of the sulcus recorded by a periodontal probe at baseline and 6 months postoperatively

Time frame: baseline and 6 months

Secondary Outcomes

Vertical bone loss change: Distance between cemento-enamel junction and base of the defect measured in standardized radiographs at baseline and 6 months postoperatively

Time frame: Baseline and 6 months

Probing depth change: The distance from the gingival margin to the depth of the sulcus recorded by a periodontal probe at baseline and 6 months postoperatively

Time frame: baseline and 6 months

Radiographic defect angle change: Using the function 'angle' the defect angle can be measured by assessing the two lines that represent the root surface of the involved tooth and the bone defect surface at baseline and 6 months postoperatively

Time frame: baseline and 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.